Carl Zeiss AG Overview
Pro stress-test →Carl Zeiss AG is a medical technology company engaged in manufacturing and commercialization of optical and optoelectronic products, with a product portfolio encompassing lithography optics, microscopes, measuring technology, photomask systems, medical technology products including ophthalmic diagnostic and therapeutic products, eyeglass lenses, camera and cine lenses and binoculars. The company serves as the strategic management holding company that manages the ZEISS Group.
Strategic Profile
Pro stress-test →The Semiconductor Manufacturing Technology (SMT) business group generated €5.055 billion in revenue in FY 2024/25 with 9,349 employees. With over 60% market share, Zeiss is the clear leader in the microsurgery space. Carl Zeiss AG owns approximately 59 percent of publicly listed Carl Zeiss Meditec AG, one of the world's leading groups in the optical and optoelectronic industries.
Competitive Landscape
Pro stress-test →EssilorLuxottica is a notable competitor of Carl Zeiss Meditec in the vision care segment. In semiconductor manufacturing equipment, Zeiss competes against ASML (though ASML holds a minority stake in Zeiss SMT), Canon, and Nikon. In surgical microscopy and medical optics, Zeiss faces competition from Leica Microsystems (Danaher) and surgical equipment manufacturers like Stryker.
Industry Context
Carl Zeiss AG operates in Optical and Optoelectronic Manufacturing; Medical Technology; Semiconductor Manufacturing Equipment.
Key facts
Founded: 1846 · Headquarters: Oberkochen, Germany · Employees: 9,349 (SMT segment); ~30,000+ (total group estimated) · Revenue: €5.055B (SMT segment FY2024/25); Overall group estimated €10B+ · Market cap: N/A